These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 11257024

  • 1. Quinolone resistance in Staphylococci: activities of new nonfluorinated quinolones against molecular targets in whole cells and clinical isolates.
    Roychoudhury S, Catrenich CE, McIntosh EJ, McKeever HD, Makin KM, Koenigs PM, Ledoussal B.
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1115-20. PubMed ID: 11257024
    [Abstract] [Full Text] [Related]

  • 2. [In vitro activity of new quinolones against clinical strains of Staphylococcus aureus of the wild type and with mutations characterized by gyrA, gyrB and grlA].
    Yagüe Guirao G, Martínez-Toldos MC, Alonso Manzanares MA, Gutiérrez Zufiaurre MN, Martínez-Andrés JA, Muñoz Bellido JL, García-Rodríguez JA, Segovia Hernández M.
    Rev Esp Quimioter; 2000 Sep; 13(3):271-5. PubMed ID: 11086276
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activity of non-fluorinated quinolones (NFQs) against quinolone-resistant Escherichia coli and Streptococcus pneumoniae.
    Roychoudhury S, Twinem TL, Makin KM, McIntosh EJ, Ledoussal B, Catrenich CE.
    J Antimicrob Chemother; 2001 Jul; 48(1):29-36. PubMed ID: 11418510
    [Abstract] [Full Text] [Related]

  • 6. The anti-methicillin-resistant Staphylococcus aureus quinolone WCK 771 has potent activity against sequentially selected mutants, has a narrow mutant selection window against quinolone-resistant Staphylococcus aureus, and preferentially targets DNA gyrase.
    Bhagwat SS, Mundkur LA, Gupte SV, Patel MV, Khorakiwala HF.
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3568-79. PubMed ID: 16940059
    [Abstract] [Full Text] [Related]

  • 7. Increased antibacterial activity of DW286, a novel fluoronaphthyridone antibiotic, against Staphylococcus aureus strains with defined mutations in DNA gyrase and topoisomerase IV.
    Yun HJ, Min YH, Jo YW, Shim MJ, Choi EC.
    Int J Antimicrob Agents; 2005 Apr; 25(4):334-7. PubMed ID: 15784314
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Staphylococcus aureus mutants isolated via exposure to nonfluorinated quinolones: detection of known and unique mutations.
    Roychoudhury S, Twinem TL, Makin KM, Nienaber MA, Li C, Morris TW, Ledoussal B, Catrenich CE.
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3422-6. PubMed ID: 11709318
    [Abstract] [Full Text] [Related]

  • 10. Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against European Staphylococcus aureus isolates.
    Schmitz FJ, Fluit AC, Brisse S, Verhoef J, Köhrer K, Milatovic D.
    FEMS Immunol Med Microbiol; 1999 Dec; 26(3-4):281-7. PubMed ID: 10575140
    [Abstract] [Full Text] [Related]

  • 11. grlA and gyrA mutations and antimicrobial susceptibility in clinical isolates of ciprofloxacin- methicillin-resistant Staphylococcus aureus.
    Coskun-Ari FF, Bosgelmez-Tinaz G.
    Eur J Med Res; 2008 Aug 18; 13(8):366-70. PubMed ID: 18952518
    [Abstract] [Full Text] [Related]

  • 12. Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.
    Bogdanovich T, Esel D, Kelly LM, Bozdogan B, Credito K, Lin G, Smith K, Ednie LM, Hoellman DB, Appelbaum PC.
    Antimicrob Agents Chemother; 2005 Aug 18; 49(8):3325-33. PubMed ID: 16048943
    [Abstract] [Full Text] [Related]

  • 13. Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.
    Shultz TR, Tapsall JW, White PA.
    Antimicrob Agents Chemother; 2001 Mar 18; 45(3):734-8. PubMed ID: 11181352
    [Abstract] [Full Text] [Related]

  • 14. Susceptibilities of healthcare- and community-associated methicillin-resistant staphylococci to the novel des-F(6)-quinolone DX-619.
    Watanabe S, Ito T, Hiramatsu K.
    J Antimicrob Chemother; 2007 Dec 18; 60(6):1384-7. PubMed ID: 17890283
    [Abstract] [Full Text] [Related]

  • 15. In vitro activities of six quinolones and mechanisms of resistance in Staphylococcus aureus and coagulase-negative staphylococci.
    Linde HJ, Schmidt M, Fuchs E, Reischl U, Niller HH, Lehn N.
    Antimicrob Agents Chemother; 2001 May 18; 45(5):1553-7. PubMed ID: 11302827
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of the new quinolone WCK 771 against staphylococci.
    Jacobs MR, Bajaksouzian S, Windau A, Appelbaum PC, Patel MV, Gupte SV, Bhagwat SS, De Souza NJ, Khorakiwala HF.
    Antimicrob Agents Chemother; 2004 Sep 18; 48(9):3338-42. PubMed ID: 15328094
    [Abstract] [Full Text] [Related]

  • 17. [In vitro activity of sparfloxacin against methicillin-resistant staphylococci].
    Wallrauch C, Voss A, Milatovic D, Braveny I.
    Arzneimittelforschung; 1995 Jun 18; 45(6):723-5. PubMed ID: 7646580
    [Abstract] [Full Text] [Related]

  • 18. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
    Oğuz VA, Yapar N, Sezak N, Cavuş SA, Kurutepe S, Peksel H, Cakir N, Yüce A.
    Mikrobiyol Bul; 2009 Jan 18; 43(1):37-44. PubMed ID: 19334378
    [Abstract] [Full Text] [Related]

  • 19. Susceptibility and resistance genes to fluoroquinolones in methicillin-resistant Staphylococcus aureus isolated in 2002.
    Noguchi N, Okihara T, Namiki Y, Kumaki Y, Yamanaka Y, Koyama M, Wakasugi K, Sasatsu M.
    Int J Antimicrob Agents; 2005 May 18; 25(5):374-9. PubMed ID: 15848290
    [Abstract] [Full Text] [Related]

  • 20. Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococcus aureus.
    Fukuda H, Hori S, Hiramatsu K.
    Antimicrob Agents Chemother; 1998 Aug 18; 42(8):1917-22. PubMed ID: 9687384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.